R. Standring

621 total citations
27 papers, 483 citations indexed

About

R. Standring is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R. Standring has authored 27 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R. Standring's work include Protease and Inhibitor Mechanisms (12 papers), Peptidase Inhibition and Analysis (8 papers) and Blood properties and coagulation (6 papers). R. Standring is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Peptidase Inhibition and Analysis (8 papers) and Blood properties and coagulation (6 papers). R. Standring collaborates with scholars based in United Kingdom, Australia and Netherlands. R. Standring's co-authors include Abigail Williams, Robin Fears, H. Ferres, D.M. Moran, W. Robert McMaster, C.A. Sunderland, Frank Boulton, Martin Been, D P de Bono and Alexander Muir and has published in prestigious journals such as Journal of the American College of Cardiology, Biochemical Journal and Trends in Biochemical Sciences.

In The Last Decade

R. Standring

26 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Standring United Kingdom 10 126 116 112 92 90 27 483
Marike J. M. Jacobs Netherlands 6 100 0.8× 80 0.7× 26 0.2× 39 0.4× 47 0.5× 8 544
Masako Saka Japan 9 125 1.0× 22 0.2× 112 1.0× 76 0.8× 146 1.6× 11 461
Tadayoshi Kosugi Japan 11 182 1.4× 14 0.1× 58 0.5× 94 1.0× 50 0.6× 62 427
Kazuhiko Yamamoto Japan 8 90 0.7× 46 0.4× 15 0.1× 57 0.6× 22 0.2× 8 471
Arnaud D. Hauer Netherlands 11 172 1.4× 31 0.3× 77 0.7× 34 0.4× 23 0.3× 17 651
D L Chapman United States 6 77 0.6× 48 0.4× 14 0.1× 24 0.3× 35 0.4× 14 378
A E Berger United States 9 130 1.0× 46 0.4× 11 0.1× 42 0.5× 35 0.4× 15 487
H Okazaki Japan 9 261 2.1× 15 0.1× 39 0.3× 31 0.3× 70 0.8× 14 537
Bosco Shang Wang United States 12 162 1.3× 51 0.4× 14 0.1× 105 1.1× 33 0.4× 38 422
M Stefănescu Romania 11 174 1.4× 40 0.3× 13 0.1× 113 1.2× 22 0.2× 23 467

Countries citing papers authored by R. Standring

Since Specialization
Citations

This map shows the geographic impact of R. Standring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Standring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Standring more than expected).

Fields of papers citing papers by R. Standring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Standring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Standring. The network helps show where R. Standring may publish in the future.

Co-authorship network of co-authors of R. Standring

This figure shows the co-authorship network connecting the top 25 collaborators of R. Standring. A scholar is included among the top collaborators of R. Standring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Standring. R. Standring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonnier, J. J. R. M., et al.. (1993). Platelet function during thrombolytic therapy with anistreplase. Fibrinolysis and Proteolysis. 7(6). 401–407. 2 indexed citations
2.
Fears, Robin, Julie Hearn, R. Standring, Jeffrey L. Anderson, & Victor J. Marder. (1992). Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction. American Heart Journal. 124(2). 305–314. 34 indexed citations
3.
4.
Fears, Robin, Jeff Hearn, Brian M. Howard, et al.. (1992). Inhibition of the fibrinolytic and fibrinogenolytic activity of plasminogen activators in vitro by the antidotes ϵ-aminocaproic acid, tranexamic acid and aprotinin. Fibrinolysis and Proteolysis. 6(2). 79–86. 9 indexed citations
5.
Hearn, Julie, et al.. (1991). Pre-treatment anti-streptokinase antibody levels do not influence coronary patency achieved by anistreplase and streptokinase. Journal of the American College of Cardiology. 17(2). A153–A153. 1 indexed citations
6.
7.
Standring, R., et al.. (1988). Induction of T-Helper Cell Activity by Fragments of Rye Grass Pollen Extract Produced by Digestion with Chymotrypsin. International Archives of Allergy and Immunology. 87(4). 337–341. 5 indexed citations
8.
Hoffmann, Johannes J.M.L., et al.. (1988). Significance of antibodies to streptokinase in coronary thrombolytic therapy with streptokinase or APSAC. Fibrinolysis and Proteolysis. 2(4). 203–210. 17 indexed citations
9.
Standring, R., Robin Fears, & H. Ferres. (1988). The protective effect of acylation on the stability of APSAC (eminase) in human plasma. Fibrinolysis and Proteolysis. 2(3). 157–163. 6 indexed citations
10.
Fears, Robin, H. Ferres, & R. Standring. (1987). The Protective Effect of Acylation on the Stability of Anisoylated Plasminogen Streptokinase Activator Complex in Human Plasma. Drugs. 33(Supplement 3). 57–63. 9 indexed citations
11.
12.
Fears, Robin, H. Ferres, Martin Hibbs, & R. Standring. (1987). Consequences of Antibody Binding in Vitro on the Pharmacological Properties of Anisoylated Plasminogen Streptokinase Activator Complex. Drugs. 33(Supplement 3). 64–68. 8 indexed citations
13.
14.
Fears, Robin, H. Ferres, & R. Standring. (1987). Evidence for the Progressive Uptake of Anisoylated Plasminogen Streptokinase Activator Complex by Clots in Human Plasma in Vitro. Drugs. 33(Supplement 3). 51–56. 6 indexed citations
15.
Fears, Robin, H. Ferres, & R. Standring. (1987). The protective effect of acylation on the stability of APSAC in human plasma. Thrombosis Research. 45. 81–81. 1 indexed citations
16.
Standring, R., et al.. (1986). Human IgG Antibody Responses to Grass Pollen Antigens: Effects of Immunotherapy and Comparison of Serum and Secretory Profiles. International Archives of Allergy and Immunology. 80(3). 253–257. 6 indexed citations
17.
18.
Moran, D.M., et al.. (1984). Assessment of Anti-Streptokinase Antibody Levels in Human Sera Using a Microradioimmunoassay Procedure. Thrombosis and Haemostasis. 52(3). 281–287. 35 indexed citations
19.
Moran, D.M., R. Standring, & D.C. Henderson. (1982). Antibody Response Profiles to Components of Rye Grass Pollen Extract in Various Strains of Mice. International Archives of Allergy and Immunology. 69(2). 120–126. 2 indexed citations
20.
Williams, Abigail, W. Robert McMaster, R. Standring, & C.A. Sunderland. (1978). Differentiation antigens and glycoproteins of lymphocytes. Trends in Biochemical Sciences. 3(4). 272–274. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marike J. M. Jacobs Breakdown of academic impact, for papers by Masako Saka Breakdown of academic impact, for papers by Tadayoshi Kosugi Breakdown of academic impact, for papers by Kazuhiko Yamamoto Breakdown of academic impact, for papers by Arnaud D. Hauer Breakdown of academic impact, for papers by D L Chapman Breakdown of academic impact, for papers by A E Berger Breakdown of academic impact, for papers by H Okazaki Breakdown of academic impact, for papers by Bosco Shang Wang Breakdown of academic impact, for papers by M Stefănescu
Rankless by CCL
2026